{
  "url": "https://openlegislation.uk/human-medicines-regulations-2012/schedule-7A/paragraph-16",
  "json_url": "https://openlegislation.uk/human-medicines-regulations-2012/schedule-7A/paragraph-16.json",
  "legislation": "uksi/2012/1916",
  "legislation_title": "The Human Medicines Regulations 2012",
  "legislation_url": "https://openlegislation.uk/human-medicines-regulations-2012",
  "path": "schedule/7A/paragraph/16",
  "kind": "paragraph",
  "number": "16",
  "heading": null,
  "text": "A separate statement in respect of each of the premises mentioned in the application of—\n(a) the manufacturing, storage or distribution operations carried out at those sites, and the specific active substances to which those activities relate; and\n(b) the equipment available at those premises for carrying out those activities.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Sch. 7A inserted (20.8.2013) by The Human Medicines (Amendment) Regulations 2013 (S.I. 2013/1855), regs. 1(1), 33"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2012/1916/schedule/7A/paragraph/16",
    "retrieved_at": "2026-10-29T01:24:34.993203+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}